investigation of feasibility non-invasive blood pressure measurement in HD non-invasive blood pressure measurement
Conditions
Interventions
None listed
Sponsors
Imec Nederland
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: * Stable ESRD patient on routine haemodialysis * Age * 18 years * Informed consent * Height between 1.50 and 2 meters * Weight between 50 and 120 kilograms * BMI between 15 and 35
Exclusion criteria
Exclusion criteria: * Subjects with a known allergy to stainless steel (grade 304) or polyurethane (8400, a synthetic polymer); * Subjects who are pregnant or likely to become pregnant (very unlikely in ESRD); * Subjects with any active implantable device, such as a pacemaker, ICD or implanted infusion pump; * Subjects using medication with phototoxic side effects: - Tetracyclines - Doxycycline - Phenothiazines - Dacarbazine - Ketoprofen - Lomefloxacin (maxaquin) or other fluoroquinolones This in order to exclude the possibility of local skin irritation problems from prolonged irradiation by LED light.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study parameters/endpoints: Completion of recording good quality datasets for 30 patients over 3 consecutive dialysis sessions per patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigating possible correlations with other recorded parameters from the on-board Simband sensors for their potential to refine the accuracy of blood pressure readings. | — |
Countries
Netherlands
Outcome results
None listed